Cancer of the Breast Clinical Trials

11 recruiting

Cancer of the Breast Trials at a Glance

11 actively recruiting trials for cancer of the breast are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in St Louis, Bethesda, and Boca Raton. Lead sponsors running cancer of the breast studies include Washington University School of Medicine, Ohio State University Comprehensive Cancer Center, and National Cancer Institute (NCI).

Browse cancer of the breast trials by phase

Treatments under study

About Cancer of the Breast Clinical Trials

Looking for clinical trials for Cancer of the Breast? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer of the Breast trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer of the Breast clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI)175 enrolled1 locationNCT07067138
Recruiting
Phase 2

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

Breast CancerCancer of the Breast
Washington University School of Medicine81 enrolled1 locationNCT05837455
Recruiting
Phase 2

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Cancer of the BreastCancerAdjustment Disorder+8 more
Psyence Australia Pty Ltd87 enrolled3 locationsNCT07072728
Recruiting
Not Applicable

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

Breast CancerCancer of the Breast
Washington University School of Medicine55 enrolled1 locationNCT04968964
Recruiting
Not Applicable

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Breast CancerCancer of the BreastHER2-negative Breast Cancer+2 more
Youssef Zeidan114 enrolled2 locationsNCT06867484
Recruiting
Phase 2

DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY

Cancer of the BreastChemotherapy-induced Neuropathy
Ohio State University Comprehensive Cancer Center140 enrolled2 locationsNCT06749210
Recruiting
Phase 2

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast CancerBreast NeoplasmCancer of the Breast+1 more
Proton Collaborative Group132 enrolled9 locationsNCT01766297
Recruiting
Phase 2

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Breast CancerBreast NeoplasmsCancer of the Breast+1 more
Washington University School of Medicine50 enrolled1 locationNCT02476786
Recruiting
Not Applicable

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

Breast CancerCancer of the Breast
Washington University School of Medicine410 enrolled1 locationNCT06981208
Recruiting

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Breast CancerCancer of the Breast
Washington University School of Medicine100 enrolled1 locationNCT05972343
Recruiting
Phase 1Phase 2

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Breast CancerCancer of the BreastBreast Tumor+3 more
BriaCell Therapeutics Corporation18 enrolled1 locationNCT06471673